• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

COVID-19 and haematological malignancy: navigating a narrow strait.

作者信息

Rubinstein Samuel M, Warner Jeremy L

机构信息

University of North Carolina, Chapel Hill, NC, USA.

Vanderbilt University Medical Center, Nashville, TN 37232, USA.

出版信息

Lancet Haematol. 2020 Oct;7(10):e701-e703. doi: 10.1016/S2352-3026(20)30252-0. Epub 2020 Aug 13.

DOI:10.1016/S2352-3026(20)30252-0
PMID:32798474
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7426081/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1859/7426081/61ef401a708a/fx1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1859/7426081/61ef401a708a/fx1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1859/7426081/61ef401a708a/fx1_lrg.jpg

相似文献

1
COVID-19 and haematological malignancy: navigating a narrow strait.新型冠状病毒肺炎与血液系统恶性肿瘤：穿越狭窄海峡
Lancet Haematol. 2020 Oct;7(10):e701-e703. doi: 10.1016/S2352-3026(20)30252-0. Epub 2020 Aug 13.
2
Clinical characteristics and outcome of SARS-CoV-2-infected patients with haematological diseases: a retrospective case study in four hospitals in Italy, Spain and the Netherlands.感染新型冠状病毒肺炎的血液病患者的临床特征与转归：意大利、西班牙和荷兰四家医院的一项回顾性病例研究
Leukemia. 2020 Sep;34(9):2536-2538. doi: 10.1038/s41375-020-0960-4. Epub 2020 Jul 8.
3
Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study.意大利血液系统恶性肿瘤患者中与COVID-19严重程度相关的临床特征和危险因素：一项回顾性、多中心队列研究。
Lancet Haematol. 2020 Oct;7(10):e737-e745. doi: 10.1016/S2352-3026(20)30251-9. Epub 2020 Aug 13.
4
SARS-CoV-2 infection anxieties and general population restrictions delay diagnosis and treatment of acute haematological malignancies.新型冠状病毒2型感染焦虑和一般人群限制措施延误了急性血液系统恶性肿瘤的诊断和治疗。
Br J Haematol. 2020 Jul;190(1):e5-e8. doi: 10.1111/bjh.16785. Epub 2020 May 25.
5
COVID-19 in patients with hematological malignancies: A retrospective case series.血液系统恶性肿瘤患者中的新型冠状病毒肺炎：一项回顾性病例系列研究。
Int J Lab Hematol. 2020 Dec;42(6):e256-e259. doi: 10.1111/ijlh.13301. Epub 2020 Aug 4.
6
Multiple myeloma and COVID-19.多发性骨髓瘤与新型冠状病毒肺炎
Leukemia. 2020 Jul;34(7):1961-1963. doi: 10.1038/s41375-020-0879-9. Epub 2020 Jun 1.
7
Assessing the impact of lockdown: Fresh challenges for the care of haematology patients in the COVID-19 pandemic.评估封锁措施的影响：COVID-19大流行期间血液学患者护理面临的新挑战。
Br J Haematol. 2020 Jun;189(6):e224-e227. doi: 10.1111/bjh.16782. Epub 2020 May 23.
8
The Impact of COVID-19 on Italy: A Lesson for the Future.新冠疫情对意大利的影响：未来之鉴。
Int J Occup Environ Med. 2020 Jul 10;11(3):151-152. doi: 10.34172/ijoem.2020.1984. Epub 2020 Mar 30.
9
Routine haematological parameters in COVID-19 prognosis.新冠病毒病预后中的常规血液学参数
Lancet Haematol. 2020 Oct;7(10):e709. doi: 10.1016/S2352-3026(20)30286-6.
10
Increase in the severity of acute malignant hemopathies during the COVID-19 pandemia.新型冠状病毒肺炎大流行期间急性恶性血液病严重程度增加。
Med Clin (Barc). 2020 Sep 25;155(6):269-270. doi: 10.1016/j.medcli.2020.06.002. Epub 2020 Jun 12.

引用本文的文献

1
De novo AML spontaneously achieved PR after COVID-19 infection, and CR after reduced dose of azacytidine combined with venetoclax: A case report and literature review.初发急性髓系白血病在新冠病毒感染后自发达到部分缓解，在低剂量阿扎胞苷联合维奈克拉治疗后达到完全缓解：一例病例报告及文献综述
Medicine (Baltimore). 2025 Apr 25;104(17):e42039. doi: 10.1097/MD.0000000000042039.
2
Cerebrovascular accident in a child with precursor B-cell acute lymphoblastic leukemia and coronavirus disease 2019: a case report.儿童前体 B 细胞急性淋巴细胞白血病合并 2019 年冠状病毒病导致的脑血管意外：病例报告。
J Med Case Rep. 2022 Dec 6;16(1):452. doi: 10.1186/s13256-022-03672-5.
3

本文引用的文献

1
Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study.意大利血液系统恶性肿瘤患者中与COVID-19严重程度相关的临床特征和危险因素：一项回顾性、多中心队列研究。
Lancet Haematol. 2020 Oct;7(10):e737-e745. doi: 10.1016/S2352-3026(20)30251-9. Epub 2020 Aug 13.
2
Factors associated with COVID-19-related death using OpenSAFELY.使用 OpenSAFELY 分析与 COVID-19 相关死亡的因素。
Nature. 2020 Aug;584(7821):430-436. doi: 10.1038/s41586-020-2521-4. Epub 2020 Jul 8.
3
Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study.
COVID-19 in Patients with Hematologic Malignancies: Outcomes and Options for Treatments.
COVID-19 于血液系统恶性肿瘤患者：结局与治疗选择。
Acta Haematol. 2022;145(3):244-256. doi: 10.1159/000522436. Epub 2022 Feb 8.
4
Clinical Characteristics and Risk Factors of COVID-19 in 60 Adult Cancer Patients.60例成年癌症患者新冠病毒病的临床特征及危险因素
Clin Med Insights Oncol. 2022 Jan 28;16:11795549221074168. doi: 10.1177/11795549221074168. eCollection 2022.
5
Optimal Management of the Public and Patients by Pharmacists in the Era of COVID-19: An Evidence-Based Review and Practical Recommendations.新冠疫情时代药师对公众和患者的最佳管理：基于证据的综述及实用建议
Front Public Health. 2022 Jan 11;9:758325. doi: 10.3389/fpubh.2021.758325. eCollection 2021.
6
Haematological malignancies implications during the times of the COVID-19 pandemic.COVID-19大流行期间血液系统恶性肿瘤的影响
Oncol Lett. 2021 Dec;22(6):856. doi: 10.3892/ol.2021.13117. Epub 2021 Oct 29.
7
Genomic Evolution of SARS-CoV-2 Virus in Immunocompromised Patient, Ireland.爱尔兰免疫功能低下患者体内 SARS-CoV-2 病毒的基因组进化。
Emerg Infect Dis. 2021 Sep;27(9):2499-2501. doi: 10.3201/eid2709.211159. Epub 2021 Jun 23.
8
The impact of primary care supported shielding on the risk of mortality in people vulnerable to COVID-19: English sentinel network matched cohort study.初级保健支持性隔离对易感染 COVID-19 人群死亡率的影响：英国哨点网络匹配队列研究。
J Infect. 2021 Aug;83(2):228-236. doi: 10.1016/j.jinf.2021.04.033. Epub 2021 May 15.
9
Being a Myeloproliferative Patient in COVID-19 Era: The Mytico Study.新冠疫情时代的骨髓增殖性疾病患者：Mytico研究
Front Oncol. 2021 Apr 15;11:668261. doi: 10.3389/fonc.2021.668261. eCollection 2021.
10
Hematological Abnormalities in COVID-19: A Narrative Review.新型冠状病毒肺炎相关血液学异常：一项叙述性综述。
Am J Trop Med Hyg. 2021 Feb 19;104(4):1188-1201. doi: 10.4269/ajtmh.20-1536.
COVID-19 对癌症患者的临床影响（CCC19）：一项队列研究。
Lancet. 2020 Jun 20;395(10241):1907-1918. doi: 10.1016/S0140-6736(20)31187-9. Epub 2020 May 28.
4
Patients with Cancer Appear More Vulnerable to SARS-CoV-2: A Multicenter Study during the COVID-19 Outbreak.癌症患者似乎更容易感染 SARS-CoV-2：COVID-19 爆发期间的一项多中心研究。
Cancer Discov. 2020 Jun;10(6):783-791. doi: 10.1158/2159-8290.CD-20-0422. Epub 2020 Apr 28.
5
COVID-19 in persons with haematological cancers.COVID-19 与血液系统恶性肿瘤。
Leukemia. 2020 Jun;34(6):1637-1645. doi: 10.1038/s41375-020-0836-7. Epub 2020 Apr 24.
6
Oncology Practice During the COVID-19 Pandemic.COVID-19大流行期间的肿瘤学实践
JAMA. 2020 May 26;323(20):2005-2006. doi: 10.1001/jama.2020.6236.
7
Clinical characteristics of COVID-19-infected cancer patients: a retrospective case study in three hospitals within Wuhan, China.COVID-19 感染癌症患者的临床特征：中国武汉三家医院的回顾性病例研究。
Ann Oncol. 2020 Jul;31(7):894-901. doi: 10.1016/j.annonc.2020.03.296. Epub 2020 Mar 26.
8
Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China.《武汉 2019 年新型冠状病毒感染的肺炎 138 例住院患者临床特征分析》
JAMA. 2020 Mar 17;323(11):1061-1069. doi: 10.1001/jama.2020.1585.
9
Effects of daratumumab on natural killer cells and impact on clinical outcomes in relapsed or refractory multiple myeloma.达雷妥尤单抗对自然杀伤细胞的影响及其对复发或难治性多发性骨髓瘤临床结局的影响。
Blood Adv. 2017 Oct 24;1(23):2105-2114. doi: 10.1182/bloodadvances.2017006866.
10
Risk factors for febrile neutropenia among patients with cancer receiving chemotherapy: A systematic review.癌症化疗患者中性粒细胞减少性发热的危险因素：系统评价。
Crit Rev Oncol Hematol. 2014 Jun;90(3):190-9. doi: 10.1016/j.critrevonc.2013.12.006. Epub 2013 Dec 12.